← Open Payments lookup

MOUHANAD AL-FAKIH: Open Payments

NPI 1013914605 · CONNELLSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,409 in 105 payments from 17 companies in 2025. Trend: 2023 $1,874 · 2024 $2,192 · 2025 $2,409

Food & beverage: $2,297Education: $111
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP19$627
Novo Nordisk Inc17$394
Teva Pharmaceuticals USA, Inc.10$274
GlaxoSmithKline, LLC.12$231
Otsuka America Pharmaceutical, Inc.8$149
Aimmune Therapeutics, Inc.8$146
Bayer Healthcare Pharmaceuticals Inc.7$113
Lundbeck LLC4$88
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$78
Boehringer Ingelheim Pharmaceuticals, Inc.4$69

Products named: AIRSUPRA, BREZTRI, REXULTI, TRELEGY ELLIPTA, AUSTEDO XR, ZENPEP, FARXIGA, Kerendia.

Industry payments across PA — which companies pay providers there.